Risk stratification of ER‐positive breast cancer patients: A multi‐institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX ® recurrence score <26-Reference-Cited by-同舟云学术

Risk stratification of ER‐positive breast cancer patients: A multi‐institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX ® recurrence score <26

Published:2019-06-14 Issue:9 Volume:8 Page:4176-4188
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Turner Bradley M.¹^ORCID,Gimenez‐Sanders Mary Ann²,Soukiazian Armen³,Breaux Andrea C.²,Skinner Kristin⁴,Shayne Michelle⁵,Soukiazian Nyrie⁶,Ling Marilyn⁷,Hicks David G.⁸

Affiliation:

1. Department of Pathology and Laboratory Medicine University of Rochester Rochester New York

2. Department of Pathology and Laboratory Medicine University of Louisville Louisville Kentucky

3. University of Rochester Rochester New York

4. Department of Surgery University of Rochester Medical Center Rochester New York

5. Department of Medical Oncology University of Rochester Rochester New York

6. Drexel University College of Medicine Graduate School of Biomedical and Professional Studies Philadelphia Pennsylvania

7. Department of Radiation Oncology University of Rochester Rochester New York

8. Department of Pathology and Laboratory Medicine University of Rochester Medical Center Rochester New York

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2323

Reference61 articles.

1. Molecular Pathology of Breast Cancer

2. Molecular evolution of breast cancer

3. Pathologic diagnosis, immunohistochemistry, multigene assays and breast cancer treatment: progress toward “precision” cancer therapy

4. Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward “precision” cancer therapy

5. Gene expression profiling predicts clinical outcome of breast cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Correlation of Magee Equations and Oncotype Dx Recurrence Score in Mexican Patients Diagnosed with Early Breast Cancer;2024

2. Development and validation of a point-based scoring system for predicting axillary lymph node metastasis and disease outcome in breast cancer using clinicopathological and multiparametric MRI features;Cancer Imaging;2023-06-01

3. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing;Cancers;2023-01-31

4. The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations;Cancers;2023-01-28

5. The Story of the Magee Equations: The Ultimate in Applied Immunohistochemistry;Applied Immunohistochemistry & Molecular Morphology;2022-09-21